Skip to main content

Articles

Recent Articles

Labcorp expands drug development solutions with acquisition of Sciformix
Articles  —  7 June Jun 2021

Labcorp expands drug development solutions with acquisition of Sciformix

Read More about Labcorp expands drug development solutions with acquisition of Sciformix
Biodistribution Assessment of Lipid Nanoparticle-Mediated mRNA Delivery Using In Vivo Imaging
Articles  —  18 February Feb 2025

Biodistribution Assessment of Lipid Nanoparticle-Mediated mRNA Delivery Using In Vivo Imaging

Read More about Biodistribution Assessment of Lipid Nanoparticle-Mediated mRNA Delivery Using In Vivo Imaging
Labcorp and its subsidiaries continue as a UnitedHealthcare preferred laboratory network provider for 2020-2021
Articles  —  24 July Jul 2020

Labcorp and its subsidiaries continue as a UnitedHealthcare preferred laboratory network provider for 2020-2021

Read More about Labcorp and its subsidiaries continue as a UnitedHealthcare preferred laboratory network provider for 2020-2021
Expediting timelines and enhancing quality for central labs global study startup
Articles  —  7 June Jun 2021

Expediting timelines and enhancing quality for central labs global study startup

Read More about Expediting timelines and enhancing quality for central labs global study startup
Quantifying in vivo Biodistribution and Kinetics of Your Biologic or Nanomaterial
Articles  —  23 April Apr 2021

Quantifying in vivo Biodistribution and Kinetics of Your Biologic or Nanomaterial

Read More about Quantifying in vivo Biodistribution and Kinetics of Your Biologic or Nanomaterial
Five Benefits of Risk-Based Quality Management (RBQM) for Clinical Trial Data
Articles  —  3 June Jun 2021

Five Benefits of Risk-Based Quality Management (RBQM) for Clinical Trial Data

Read More about Five Benefits of Risk-Based Quality Management (RBQM) for Clinical Trial Data
Labcorp and EmblemHealth announce strategic collaboration to serve over 3 million members In New York communities
Articles  —  22 February Feb 2021

Labcorp and EmblemHealth announce strategic collaboration to serve over 3 million members In New York communities

Read More about Labcorp and EmblemHealth announce strategic collaboration to serve over 3 million members In New York communities
Is a different recruitment strategy required to enroll RA biosimilar studies? How to succeed despite increasing volume of RA biosimilar development programs
Articles  —  7 June Jun 2021

Is a different recruitment strategy required to enroll RA biosimilar studies? How to succeed despite increasing volume of RA biosimilar development programs

Read More about Is a different recruitment strategy required to enroll RA biosimilar studies? How to succeed despite increasing volume of RA biosimilar development programs
Road map of real world evidence (RWE) in Europe
Articles  —  17 June Jun 2020

Road map of real world evidence (RWE) in Europe

Read More about Road map of real world evidence (RWE) in Europe
Understanding Regulatory and Market Access Considerations With Drug Abuse Potential
Articles  —  19 May May 2021

Understanding Regulatory and Market Access Considerations With Drug Abuse Potential

Read More about Understanding Regulatory and Market Access Considerations With Drug Abuse Potential
A Successful Remote Monitoring Strategy for Clinical Studies
Articles  —  31 January Jan 2021

A Successful Remote Monitoring Strategy for Clinical Studies

Read More about A Successful Remote Monitoring Strategy for Clinical Studies
Accelerating Rare Disease and Orphan Drug Development: Opportunities for Biomarkers, Diagnostics & Patient Engagement
Articles  —  19 May May 2021

Accelerating Rare Disease and Orphan Drug Development: Opportunities for Biomarkers, Diagnostics & Patient Engagement

Read More about Accelerating Rare Disease and Orphan Drug Development: Opportunities for Biomarkers, Diagnostics & Patient Engagement